Clinical Trial Update: Post Marketing Study in Subjects Who Have Type 2 Diabetes Using the EndoBarrier™ Gastrointestinal Liner [NA]

View source ↗

Summary

Post-marketing study results for the EndoBarrier Gastrointestinal Liner in subjects with Type 2 diabetes mellitus and obesity; the study is completed and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• EndoBarrier Gastrointestinal Liner

Snippet

Sponsor: Morphic Medical Inc. | Conditions: Type 2 Diabetes, Obesity | NA | Status: COMPLETED | Results posted: 2017-02-20